Infectious Diseases News and Research

RSS

Lewin-Cameron Laboratory at Doherty Institute selects OpenSpecimen system to manage biospecimens inventory

In the short time that AXT have been promoting OpenSpecimen, the bioinformatics platform for managing biospecimens inventory developed by Krishagni Solutions in conjunction with the National Cancer Institute, it has generated large amounts of interest in Australia.

From AXT Pty Ltd 2 Mar 2016

Study finds wide disparities in access to surgery between rich and poor countries

The volume of surgery has increased globally over the last decade but wide disparities in access to surgery persist between rich and poor countries, according to a study published today in the Bulletin of the World Health Organization.

2 Mar 2016

Children's Hospital Colorado study outlines preparedness for future enterovirus D68 outbreaks

From August to September 2014, a typically slow time for respiratory viruses, a nationwide outbreak of enterovirus D68 left resources constrained for Children's Hospital Colorado and pediatric organizations throughout the nation.

2 Mar 2016

"Neoehrlichiosis" Internationally Diagnosed And Successfully Treated In Patients Without Immunodeficiency For The First Time

The intercellular bacteria "Candidatus Neoehrlichia", as e.g. Borrelia, can be transferred by ticks. Approx. 4.2 % of indigenous ticks are infected with this rarely explored bacterium which, until today, has been exclusively identified as pathogenic bacterium in patients with an impairment of the immune system, such as in case of leukaemia, rheumatism or after organ transplantation.

1 Mar 2016

Single antibody could hold promise as potential treatment for human cases of EVD

A single monoclonal antibody isolated from a human survivor of Ebola virus disease (EVD) completely protected monkeys from lethal infection with the virus, according to research published in today's online edition of the journal Science.

27 Feb 2016

Novel way proposed for developing infectious disease models to uncover hidden patterns of transmission

Ebola. Chikungunya. Zika. Once rare and exotic pathogens keep popping up and turning into household names. It's the new reality as the climate warms, humans expand more into wildlife habitats and air travel shrinks the distances across the globe.

27 Feb 2016

Researchers identify, isolate and characterize two Ebola virus neutralizing monoclonal antibodies

The Institute for Research in Biomedicine, affiliated to the Università della Svizzera italiana, and Humabs BioMed SA, a Swiss antibody therapeutics company, have identified, isolated and characterized two Ebola virus neutralizing monoclonal antibodies from the blood of a survivor of an Ebola infection.

27 Feb 2016

P. gingivalis could be a novel risk factor for esophageal cancer

University of Louisville School of Dentistry researchers have found a bacterial species responsible for gum disease, Porphyromonas gingivalis, is present in 61 percent of patients with esophageal squamous cell carcinoma (ESCC).

27 Feb 2016

WRAIR researchers publish results from Plasmodium vivax malaria vaccine study

Walter Reed Army Institute of Research researchers recently published the results of testing a Plasmodium vivax malaria vaccine candidate in a human challenge model.

27 Feb 2016

Understanding range of neurological disease linked with Zika virus is urgent priority, warn researchers

Understanding the scale and range of neurological disease associated with Zika virus infection is an urgent priority, warn researchers from the University of Liverpool's Institute of Infection and Global Health.

27 Feb 2016

Researchers conduct study of Ebola survivors in Sierra Leone

Researchers from the University's Institute of Translational Medicine have conducted a study of Ebola survivors to describe the medical problems they continue to have after recovering from the acute disease.

27 Feb 2016

New ways to monitor physical activity at workplace

The science of physical activity at work remains understudied despite widespread acceptance that it plays an important role in health. Now, researchers at the Colorado School of Public Health at the University of Colorado Anschutz Medical Campus have published a comprehensive review of ways to monitor physical activity and tools for occupational exposure scientists.

26 Feb 2016

Luminex collaborates with University of São Paulo to validate multi-analyte Zika virus assay

Luminex Corporation today announced it is collaborating with the Laboratory of Molecular Evolution & Bioinformatics, Biomedical Sciences Institute, University of São Paulo, Brazil to validate a multi-analyte Zika virus assay developed by Luminex partner, GenArraytion, Inc.

26 Feb 2016

Maraviroc drug safe, well-tolerated when taken as PrEP to prevent HIV infection

Maraviroc, an oral drug used to treat HIV infection, is safe and well-tolerated when taken daily as pre-exposure prophylaxis (PrEP) to prevent HIV infection by HIV-uninfected men who have sex with men (MSM) at increased risk for acquiring HIV.

25 Feb 2016

Zika outbreak highlights need for developing and evaluating new vaccines for pregnant women

The recent outbreak of Zika virus disease and its link to fetal development highlights the need for pregnant women and those of reproductive age to be a priority group for developing and evaluating new vaccines and vaccine guidelines for Zika and other emerging infectious diseases, say the authors of a new Viewpoint article in JAMA.

25 Feb 2016

Two investigational Ebola vaccines well-tolerated in Phase 2 clinical trial

Two investigational vaccines designed to protect against Ebola virus disease were well-tolerated and induced an immune response among 1,000 vaccinated participants in the Phase 2 randomized, placebo-controlled clinical trial called PREVAIL I.

25 Feb 2016

Ebola survivors and close contacts have high burden of illness

Preliminary findings from PREVAIL III, a study of Ebola virus disease (EVD) survivors being conducted in Liberia, indicate that both Ebola survivors and their close contacts have a high burden of illness. However, the prevalence of eye, musculoskeletal, and neurological complications was greater among the individuals who survived EVD.

25 Feb 2016

Sangamo presents immunological data from SB-728-T HIV clinical study at CROI 2016

Sangamo BioSciences, Inc., the leader in therapeutic genome editing, announced the presentation of immunological data from the Company's clinical trials of SB-728-T, a ZFP Therapeutic designed to provide functional control of HIV.

25 Feb 2016

Study: Most Ebola survivors experience brain symptoms more than six months after initial infection

Most of the 82 Ebola survivors in a new study from the world's largest Ebola outbreak had brain symptoms more than six months after the initial infection. The preliminary results will be presented at the American Academy of Neurology's 68th Annual Meeting in Vancouver, Canada, April 15 to 21, 2016.

25 Feb 2016

Study highlights presence of antibiotic stewardship practices in most VA-affiliated facilities

New research highlights the robust presence of antibiotic stewardship practices in most Veterans Administration-affiliated facilities, manifested in both formal and informal policies. The study was published online today in Infection Control & Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America.

24 Feb 2016

Infectious Diseases News and Research

Lewin-Cameron Laboratory at Doherty Institute selects OpenSpecimen system to manage biospecimens inventory

Study finds wide disparities in access to surgery between rich and poor countries

Children's Hospital Colorado study outlines preparedness for future enterovirus D68 outbreaks

"Neoehrlichiosis" Internationally Diagnosed And Successfully Treated In Patients Without Immunodeficiency For The First Time

Single antibody could hold promise as potential treatment for human cases of EVD

Novel way proposed for developing infectious disease models to uncover hidden patterns of transmission

Researchers identify, isolate and characterize two Ebola virus neutralizing monoclonal antibodies

P. gingivalis could be a novel risk factor for esophageal cancer

WRAIR researchers publish results from Plasmodium vivax malaria vaccine study

Understanding range of neurological disease linked with Zika virus is urgent priority, warn researchers

Researchers conduct study of Ebola survivors in Sierra Leone

New ways to monitor physical activity at workplace

Luminex collaborates with University of São Paulo to validate multi-analyte Zika virus assay

Maraviroc drug safe, well-tolerated when taken as PrEP to prevent HIV infection

Zika outbreak highlights need for developing and evaluating new vaccines for pregnant women

Two investigational Ebola vaccines well-tolerated in Phase 2 clinical trial

Ebola survivors and close contacts have high burden of illness

Sangamo presents immunological data from SB-728-T HIV clinical study at CROI 2016

Study: Most Ebola survivors experience brain symptoms more than six months after initial infection

Study highlights presence of antibiotic stewardship practices in most VA-affiliated facilities

NGS for Infectious Disease Surveillance eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News